RAKEIORA
| Full title: | Rakeiora Cancer Genomic Medicine Research Pathfinder Study: A pathfinder program to develop and test infrastructure for genomic medicine research in Aotearoa New Zealand. |
| Cancer type: | All cancers including blood cancers |
| Status: | No longer recruiting |
|
Brief description:
|
The aim of the Rakeiora Study is to develop an initial, proof-of-concept, cancer genomic research infrastructure that will be the foundation for a scalable national cancer genomics research infrastructure. Objectives:
This study plans to recruit 100 participants with any type of cancer. A cancer tissue sample (stored tissue sample or blood sample) and a normal tissue sample (blood sample or nail clipping/cheek swab) will be collected from each participant. |
| Sites: | Auckland |
| Lead Investigator: | Professor Cris Print (University of Auckland), Dr Helen Wihongi (Auckland & Waitematā DHB) |
| Contact: | Jade Scott (j.scott@auckland.ac.nz) |
| Sponsor: | University of Auckland |
| Funder: | Ministry of Business, Innovation & Employment (MBIE) through Genomics Aotearoa (GA) |
| Trial Registry reference: | Universal Trial Number (UTN): U1111-1274 |
| Ethics number: | 2022 EXP 11206 |
| Publications: | None currently |
Rakeiora Study Advertisement
